Results 31 to 40 of about 11,435 (218)

Toxic Epidermal Necrolysis after Pemetrexed and Cisplatin for Non-Small Cell Lung Cancer in a Patient with Sharp Syndrome [PDF]

open access: yes, 2012
Background: Pemetrexed is an antifolate drug approved for maintenance and second-line therapy, and, in combination with cisplatin, for first-line treatment of advanced nonsquamous non-small cell lung cancer.
Müller, Daniel   +5 more
core   +1 more source

Increased predisposition of sjs ten in COVID-19 patients, presenting as post COVID complication: Report of two cases

open access: yesIndian Dermatology Online Journal, 2022
We report two consecutive cases of toxic epidermal necrolysis presented to our emergency department in the past 5 months. Both patients had history of fever prior to the onset of skin manifestations and showed radiological findings suggestive of COVID-19
Shayna Aulakh   +3 more
doaj   +1 more source

Amoxicillin induced toxic epidermal necrolysis

open access: yes, 2020
Toxic epidermal necrolysis (TEN) is a rare life-threatening adverse drug reaction associated with mucocutaneous eruptions and peeling of skin (sloughing) mostly caused by drugs like sulphonamides, beta lactams, carbamazepine and non-steroidal anti ...
Narasimha G., Lakshmi, P., Kalpana
core   +1 more source

Clinical features of Stevens — Johnson syndrome and toxic epidermal necrolysis: An observational cohort retrospective study

open access: yesКубанский научный медицинский вестник
Background. Stevens — Johnson syndrome and toxic epidermal necrolysis are severe diseases featuring lesions of the mucous membranes and skin, with a possible lethal outcome. These diseases are most often triggered by various infections and medications, e.
G. M. Nurtdinova   +6 more
doaj   +1 more source

Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Toxic epidermal necrolysis lies within the spectrum of severe cutaneous adverse reactions induced by drugs, affecting skin and mucous membranes.
Kamal Tamer   +3 more
doaj   +1 more source

Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review

open access: yes, 2011
The aims of this review are to summarize the definitions, causes, and clinical course as well as the current understanding of the genetic background, mechanism of disease, and therapy of toxic epidermal necrolysis and Stevens-Johnson ...
Mathias Nelle   +5 more
core   +1 more source

Toxic Epidermal Necrolysis: Reply [PDF]

open access: yesMedical Journal Armed Forces India, 2007
Dear Editor, The authors wish to thank the reader for the keen interest shown in the article and for his compliments. We would like to clarify the issues raised by him. Toxic Epidermal Necrolysis (TEN) has been reported to develop due to corticosteroids as well as in spite of steroid therapy [1].
N, Kumar, N S, Walia
openaire   +2 more sources

Carbamazepine-Induced Toxic Epidermal Necrolysis

open access: yesJournal of Integrated Health Sciences, 2018
Toxic epidermal necrolysis (TEN) is an uncommon; however, life-threatening dermatological condition which occurs most frequently by the use of drugs. Some group of medications, such as antiepileptics, antibiotics as well as antivirals, can induce such ...
Kushal Gohel   +3 more
doaj   +1 more source

Carbamzepine-induced toxic epidermal necrolysis

open access: yes, 2011
Toxic epidermal necrolysis (TEN), also known as Lyell′s syndrome, is a widespread life-threatening mucocutaneous disease where there is extensive detachment of the skin and mucous membrane.
Ramapuram, John   +4 more
core   +2 more sources

PHENYTOIN INDUCED TOXIC EPIDERMAL NECROLYSIS; A CASE REPORT

open access: yes, 2017
Several drugs are at high risk of causing Toxic Epidermal Necrolysis (TEN) including Anti-convulsants such as phenytoin, carbamazepine and phenobarbital.
PHENYTOIN INDUCED TOXIC EPIDERMAL NECROLYSIS; A CASE REPORT Merphin Philip Thomas*1, Miriam Lalmuanpuii Hnamte1, Sina Zare1, Teena Nazeem
core   +1 more source

Home - About - Disclaimer - Privacy